Biophotonic imaging technology developer Xenogen has debuted IVIS 3D, a three-dimensional biophotonic imaging system designed to aid drug discovery and development.
The unit offers full 3D diffuse tomographic analysis of bioluminescent light sources in living animals, as well as 2D multiview fluorescent imaging capabilities, according to the Alameda, CA-based firm. It captures and processes numerous views/orientations taken around a mouse to provide researchers with better spatial representations of light sources, Xenogen said.
The surface topography measurements can be co-registered with other modalities such as CT and MRI, Xenogen said. Evaluation units of IVIS 3D have been installed at several institutions, including the Children's Hospital Los Angeles and the Hospital for Sick Children in Toronto.
By AuntMinnie.com staff writers
September 8, 2005
Related Reading
Xenogen launches 3D software, March 17, 2005
Xenogen licenses technology to MIR Preclinical Services, April 12, 2005
Xenogen plans IPO, July 16, 2004
Copyright © 2005 AuntMinnie.com
